Medical Utilization in Israel During Second Intifada

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2006 by Sheba Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00350675
First received: July 9, 2006
Last updated: NA
Last verified: July 2006
History: No changes posted

July 9, 2006
July 9, 2006
July 2006
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Medical Utilization in Israel During Second Intifada
Medical Utilization, Psychotropic Prescriptions, and Somatic Complaints in Israel During the Second Intifada: An Ecological Study of the Impact of Stress.

In this ecological study we examine the impact of stress from repeated terrorist attacks during the second initifada on medical utilization by the Israeli population. We hypothesize that in weeks following serious terror attacks there will be an increase in prescriptions for psychiatric medications and an increased number of unexplained somatic complaints. We will also examine associations with overall medical utlization. We will consider age, gender and effects of geographic poximity to location of attacks.

Not Provided
Observational
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective
Not Provided
Not Provided
Not Provided
Not Provided
  • Anxiety
  • Depression
  • Stress
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

Ecological study We will examine patterns of visits and prescirptions for all participants in two large health provider institutions in Israel.

Exclusion Criteria:

None - ecological study

Both
Not Provided
No
Contact: Joshua D Lipsitz, PhD 972-3-530-3505 ext 114 joshual@gertner.health.gov.il
Not Provided
 
NCT00350675
SHEBA-06-4194-RG-CTIL
Not Provided
Not Provided
Sheba Medical Center
Not Provided
Principal Investigator: Joshua D Lipsitz, PhD Gertner Institute, Sheba Medical Center
Study Chair: Raz Gross, MD Gertner Institute, Sheba Medical Center
Sheba Medical Center
July 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP